Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients

Nephrol Dial Transplant. 2023 May 31;38(6):1567-1570. doi: 10.1093/ndt/gfad017.

Authors

Yuan Cheng¹, Qiong Xiang^{1

2}, Tao Cao¹, Fei Tang¹, Jia Chen¹, Dongli Qi¹, Haofei Hu¹, Haiying Song¹, Zheyi Chang¹, Ming Ku¹, Xinglin Chen³, Chi Chen⁴, Qijun Wan¹

Affiliations

¹ Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, P.R. China.
² Shantou University Medical College, Shantou, Guangdong, P.R. China.
³ Department of Epidemiology and Biostatistics, Empower U, X&Y Solutions Inc., Boston, MA, USA.
⁴ Department of Immunology and Microbiology, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China.

PMID: 36662034
DOI: 10.1093/ndt/gfad017

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anemia*
Glycine
Humans
Isoquinolines
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy
Thyroid Gland

Substances

Glycine
Isoquinolines